期刊文献+

氯吡格雷抵抗的研究进展 被引量:3

下载PDF
导出
摘要 血液中的血小板在维持血管的完整性方面起着重要作用。血管内皮损伤后,循环中的血小板通过其GPⅡb/Ⅲa受体迅速与损伤部位相结合,释放各种活化因子,产生血小板聚集,受损部位被血小板覆盖,在凝血酶和胶原存在时,激活周围的血小板而发生连锁反应,血小板聚集形成血栓。血小板膜上的GPⅡb/Ⅲa受体是各种因素致血小板聚集的最终共同途径。
作者 张倩 孙福成
出处 《中国心血管杂志》 2009年第5期410-412,共3页 Chinese Journal of Cardiovascular Medicine
  • 相关文献

参考文献11

  • 1Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol, 2005,45:1157- 1164.
  • 2Saw J, Brennan DM, Steinhubl SR, et al. Lack of evidence of a clopidogrel-statin interaction in the CHARISMA trial. J Am Coll Cardiol, 2007, 50:291-295.
  • 3Lau WC,Gurbel PA, Watkins PB, et al. Contibution of hepatic cytochrome P450 3A4 metabolic activity to the phenomenon of clopidogrel resistance. Circulation, 2004, 109 : 166-171.
  • 4Angiolillo D J, Fernandez-Ortiz A, Bernardo E, et al. Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives. J Am Coll Cardiol, 2007, 49 : 1505-1516.
  • 5Gurbel PA,Bliden KP, Samara W, et al. Clopidogrel effect on platelet reactivity in patients with stent thrombosis :results of the CREST study. J Am Coll Cardiol, 2005, 46:1827-1832.
  • 6Buonamici P, Marcucci R, Migliorini A, et al. Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis. J Am Coll Cardiol, 2007, 49:2512-2517.
  • 7Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J, 2006, 27:2420-2425.
  • 8Taubert D, Kastrati A, Harlfinger S, et al. Pharmacokinetics of clopidogrel after administration of a high loading dose. Thromb Haemost, 2004, 92:311-316.
  • 9Cuisset T, Frere C,Quilici J, et al. Benefit of a 600-rag loading dose of clopidogrel on platelet reactivity and clinical outcomes in patients with non-ST-segment elevation acute coronary syndrome undergoing coronary stenting. J Am Coll Cardiol, 2006, 48: 1339-1345.
  • 10Campo G, Valgimigli M, Gemmati D, et al. Poor responsiveness to clopidogrel: drug-specific or class-effect mechanism? Evidence from a clopidogrel-to-ticlopidine crossover study. J Am Coll Cardiol, 2007, 50 : 1132-1137.

同被引文献27

  • 1任宏生,朱兴雷.氯吡格雷防治动脉粥样硬化缺血性疾病的研究进展[J].心血管病学进展,2006,27(3):274-281. 被引量:29
  • 2Robert A. Harrington al. Antithrombotic therapy J, Richard C, et for non-ST segment elevation acute coronary syndromes: American College of Chest Physicians Evidence based Clinical Practice Guidelines (Sth Edition). Chest, 2008, 133: 776-814.
  • 3Quinn MJ, Bhatt DL, Zidar F, et al. Effect of clopidogrel pretreatment on inflammatory marker expression in patients undergoingpercutaneous coronary intervention. Am J Cardiol, 2004, 93: 679-684.
  • 4Gu Q, Chen JL, Ruan YM, et al. Effects of clopidogrel on the formation of experimental atherosclerosis. Chin Cir J, 2004,19:145-148.
  • 5Evangelista V, Manarini S. Clopidogrel inhibits platelet-leukocyte adhesion and platelet-dependent leukocyte activation. Thromb Haemost, 2005, 94: 568-577.
  • 6O'Donoghu M, William E, Braunwald E, et al. Early invasive vs conservative treatment strategies inWomen and men with unstable angina and non ST-segment elevation myocardial infarction, a meta- analysis. JAMA, 2008,300:71 80.
  • 7The CLARITY-TIMI 28 Investigators. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST segment elevation. N Engl J Med ,2005,352:1179-1189.
  • 8Geisler T, Langer H, Wydymus M, et al. Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation. Eur Heart J, 2006,27 : 2420-2425.
  • 9Selwyn AP. Prothrombotic and antithrombotic pathways in acute coronary syndromes. Am J Cardiol, 2003, 91 (12A) : 3H -11H.
  • 10Nguyen TA, Diodati JG, Pharand C. Resistance to clopidogrel: a review of the evidence. J Am Coll Cardiol, 2005, 45:1157-1164.

引证文献3

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部